Breaking News

Applied DNA Acquires RNA Polymerase Developer Spindle Biotech

Platform enables customers to manufacture mRNA with substantial reduction in dsRNA and manufacturing complexities.

Applied DNA Sciences, Inc. a company involved with PCR-based DNA technologies, acquired Spindle Biotech Inc., an early-stage, private biotech company developing next-generation RNA manufacturing technologies. The acquisition leverages the company’s LinearDNA platform that enables efficient chemical modification of DNA templates and the high binding affinity of Spindle’s high-performance RNA polymerase (RNAP) for chemically modified DNA templates. The goal is to deliver multiple ad...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters